Drug intelligence / Profile preview

Neuramis Deep

Development stage
Unknown
Lead developer
Medytox
Administration
Intradermal, Subcutaneous
01

Overview

Neuramis Deep is a monophasic, cross-linked hyaluronic acid-based dermal filler developed by the South Korean biopharmaceutical company Medytox Inc. It is manufactured using proprietary SHAPE (Stable Hyaluronic Acid and Purification Enhancement) technology, which involves a two-step cross-linking process and enhanced purification to ensure safety and long-lasting results. The product contains 20 mg/mL of non-animal-derived stabilized hyaluronic acid (NASHA) and is primarily indicated for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds and marionette lines, as well as for lip augmentation and facial volume restoration. Clinical studies have demonstrated its non-inferiority to established fillers like Restylane in terms of efficacy and safety. Some versions of the product are formulated with 0.3% lidocaine to minimize patient discomfort during the injection process.

Brand names
Neuramis Deep
Other names
Neuramis

Beyond the preview

Go deeper on Neuramis Deep.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuramis Deep.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call